BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27926487)

  • 21. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
    Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
    J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
    Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
    Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
    Yu CC; Chang YC
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple drug resistant, tumorigenic stem-like cells in oral cancer.
    Richard V; Sebastian P; Nair MG; Nair SN; Malieckal TT; Santhosh Kumar TR; Pillai MR
    Cancer Lett; 2013 Sep; 338(2):300-16. PubMed ID: 23791883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44
    de Andrade NP; Rodrigues MF; Rodini CO; Nunes FD
    Pathol Res Pract; 2017 Mar; 213(3):235-244. PubMed ID: 28214216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment.
    Hu FW; Tsai LL; Yu CH; Chen PN; Chou MY; Yu CC
    Mol Nutr Food Res; 2012 Aug; 56(8):1247-58. PubMed ID: 22692956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Zhou SF; Qiu JX
    Drug Des Devel Ther; 2015; 9():5511-51. PubMed ID: 26491260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
    Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
    Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
    Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
    Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
    Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
    Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Calderwood SK; Okamoto K; Kozaki KI
    Oral Oncol; 2018 Nov; 86():251-257. PubMed ID: 30409309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.
    Sinha A; Paul BT; Sullivan LM; Sims H; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    Oncotarget; 2017 Feb; 8(6):10114-10135. PubMed ID: 28052035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma.
    Lee SH; Rigas NK; Lee CR; Bang A; Srikanth S; Gwack Y; Kang MK; Kim RH; Park NH; Shin KH
    Oncotarget; 2016 Jul; 7(28):43239-43255. PubMed ID: 27259269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
    Han J; Fujisawa T; Husain SR; Puri RK
    BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.